<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03630744</url>
  </required_header>
  <id_info>
    <org_study_id>HTF-FLU-2018-01</org_study_id>
    <secondary_id>SED-HEA-2018-01</secondary_id>
    <nct_id>NCT03630744</nct_id>
  </id_info>
  <brief_title>Fluid Day Spanish Observational Study</brief_title>
  <acronym>Fluid Day</acronym>
  <official_title>Fluid Day: Observational Study About Fluid Therapy Administered in Adult Patients Undergoing Surgery in Our Country</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Vall d'Hebron</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Infanta Leonor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Verge dels Lliris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Doctor Peset</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Miguel Servet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario La Fe</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Perioperative fluid therapy has undergone a huge change in clinical practice in recent years.&#xD;
      The patterns of replacement and / or restoration of volemia described in the classic&#xD;
      anaesthesiology books were supported by weak scientific evidence, and a paradigm shift in&#xD;
      perioperative fluid therapy based on aspects such as increased mortality associated with an&#xD;
      excessively positive balance of fluids in the perioperative period, evidences related to the&#xD;
      non-existence of the third non-anatomical space and the need to preserve the capillary&#xD;
      endothelium and its glycocalyx.&#xD;
&#xD;
      On the other hand, advances in technology, through the availability of less invasive&#xD;
      monitoring systems, capable of determining dynamic parameters related to blood volume that&#xD;
      allow predicting the response to volume management, have provided much more adequate&#xD;
      monitoring and simple to guide such intravenous volume restoration.&#xD;
&#xD;
      Following all these changes different guidelines and recommendations have been published in&#xD;
      recent years with the intention of clarifying the current evidence and facilitate the correct&#xD;
      use of fluid therapy to clinicians, but despite this the fact is that today the investigators&#xD;
      still do not have information on how fluid therapy is administered in daily practice, so the&#xD;
      section of Hemostasis, Transfusion Medicine and Fluid Therapy of SEDAR, considered it&#xD;
      necessary to evaluate the clinical practice of fluid therapy in the perioperative period&#xD;
      through the Fluidday study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: The administration of fluids in the perioperative period is a routine clinical&#xD;
      practice that sometimes underestimates the repercussion of its correct administration.&#xD;
&#xD;
      According to the guidelines of the Spanish Society of Anesthesiology, Resuscitation and&#xD;
      Therapy of Pain (SEDAR), the objective of perioperative fluid therapy is to maintain the&#xD;
      organism with an optimal state of tissue perfusion and hydration.&#xD;
&#xD;
      This goal is not always easy to carry out. The continuous changes in surgical and anesthetic&#xD;
      techniques and the appearance of new fluids and monitoring devices make it difficult for the&#xD;
      anesthesiologist to carry out all these changes in his daily clinical practice. For this&#xD;
      reason, SEDAR and other international scientific societies have recently published guidelines&#xD;
      on the management of fluid therapy in the perioperative period, with the intention of&#xD;
      facilitating the decision making of the anesthesiologist in their usual clinical practice&#xD;
      based on current evidence. Also adding the recent withdrawal and commercial suspension of a&#xD;
      special type of fluid such as Hydroxyethylstarch.&#xD;
&#xD;
      Hypothesis: Fluid therapy in the surgical environment is administered in a protocolized&#xD;
      manner and in accordance with the recommendations of the different clinical practice&#xD;
      guidelines.&#xD;
&#xD;
      Objectives: To evaluate the management of fluid therapy by anesthesiologists in adult&#xD;
      patients during the perioperative period of scheduled and urgent surgery, taking into account&#xD;
      the types of fluids administered, the monitoring used and the application of guided therapy&#xD;
      protocols by objectives.&#xD;
&#xD;
      Methods: A multicenter prospective observational cross-sectional study - 24-hour Prevalence&#xD;
      Cut off is proposed to evaluate the fluid therapy administered by anesthesiologists in&#xD;
      surgical patients. The study will be carried out simultaneously in all hospitals that decide&#xD;
      to participate throughout the Spanish territory and the follow-up period will be a maximum of&#xD;
      24 hours. Two different intersemanial days will be chosen to include the maximum number of&#xD;
      episodes and types of surgeries.&#xD;
&#xD;
      Relevance: The clinical practice guidelines with their recommendations or suggestions offer a&#xD;
      safety tool for patients based on current scientific evidence, hence the importance of its&#xD;
      correct implementation. Sometimes problems of dissemination of information or limitations in&#xD;
      the application of the same can cause that these objectives are not met.&#xD;
&#xD;
      From the Section of Hemostasis, Transfusion Medicine and Fluid Therapy of the SEDAR, it is&#xD;
      intended to assess the implementation and follow-up of the recommendations and / or&#xD;
      suggestions issued in the different clinical practice guidelines for the correct management&#xD;
      of Fluid Therapy in the perioperative setting by performing of this study. This will allow&#xD;
      locating the points of improvement in the usual clinical practice on perioperative fluid&#xD;
      therapy and will contribute on the one hand to the implementation of the different clinical&#xD;
      practice guidelines and, on the other hand, it will serve as a base material for the&#xD;
      development of future lines of research.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">February 2019</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Days</target_duration>
  <primary_outcome>
    <measure>Management of fluid theraphy in the operating room and postoperative care.</measure>
    <time_frame>Two days</time_frame>
    <description>The purpose of this study is to evaluate how fluids are administered in the Operating Room and postoperative care. We also collect data on the total amount of fluids administered and the type of fluid administered during the anesthesia procedure and surgery.&#xD;
Type of Crystalloids and total amount in mL&#xD;
Saline serum 0.9% ....... ml&#xD;
Lactated Ringer ........ ml&#xD;
Isofundin ® ........ ml&#xD;
Plasmalyte® ... ... ml&#xD;
Glusose 5% ....... ml&#xD;
Glucose 10% ........ ml&#xD;
Saline &amp; Glucose 5% ........ ml Type of Colloids and total amount in mL&#xD;
HEA 130 / 0.4 ... ... ml&#xD;
HEA 130 / 0.42 ...... .... ml&#xD;
Gelatins ... ....... ml&#xD;
Albumin 5%.......... ml&#xD;
Albumin 20% ………..ml&#xD;
Method of administration:&#xD;
Standard&#xD;
Standard with dosimeters&#xD;
In pump Use of goal-guided Fluid Therapy protocols&#xD;
YES&#xD;
NO&#xD;
Use of Hemocomponents type and total does in mL:&#xD;
RBC..........mL&#xD;
Plasma..........................ml&#xD;
Platelets ..........ml</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Monitorization</measure>
    <time_frame>Two days</time_frame>
    <description>Type of monitors used in the operating room and postoperative care.&#xD;
Standard (NIBP, ECG, SpO2)&#xD;
Invasive Blood Pressure&#xD;
PVC&#xD;
Advanced hemodynamics: Specify: □ CAP □ TTP □ DTL □ TEE □ COP □ Other&#xD;
Dynamic Preload Parameters: Specify: □ VVS □ VPS □ VPP □ IVP&#xD;
Targeted therapy protocol (Yes / No)&#xD;
PANI: Non-invasive blood pressure ECG: Electrocardiogram SpO2: Partial oxygen saturation PVC: Central venous pressure CAP: Pulmonary artery catheter GC: Cardiac output TTP: Pulmonary thermodilution DTL: Transpulmonary Lithium Dilution ETT: Transesophageal echocardiography VVS: Systolic volume variation VPS: Systolic pressure variation VPP: Pulse pressure variation IVP: Index of plethysmographic variation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Demographic</measure>
    <time_frame>Two days</time_frame>
    <description>Sex&#xD;
Female&#xD;
man Age……..years old Weight …….Kg Height ……..cms BMI ASA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Commorbidities</measure>
    <time_frame>Two days</time_frame>
    <description>Renal Insufficiency&#xD;
Yes&#xD;
No Heart Failure&#xD;
Yes&#xD;
No Cardiac valve disease&#xD;
Yes&#xD;
no Pulmonary Hypertension&#xD;
Yes&#xD;
No Hepatopathy,&#xD;
Yes&#xD;
NO Arterial Hypertension,&#xD;
Yes&#xD;
NO Ischemic Heart Disease,&#xD;
Yes&#xD;
NO Dialysis&#xD;
Yes&#xD;
NO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical procedure</measure>
    <time_frame>Two days</time_frame>
    <description>Specialty and type of intervention. Duration of the surgical intervention. Postoperative follow-up time hours</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vasoactive support</measure>
    <time_frame>Two days</time_frame>
    <description>Yes/Not, type quantity ml</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Fluid Therapy</condition>
  <arm_group>
    <arm_group_label>Adult patients undergoing surgery</arm_group_label>
    <description>Patients over 18 years surgically treated with fluid therapy during the 24 hours of the day study</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Fluid therapy</intervention_name>
    <description>Analyze the type of fluid administered:&#xD;
crystalloids:&#xD;
Saline serum 0.9% ....... ml&#xD;
Ringer Lactate ........ ml&#xD;
Isofundin ® ........ ml&#xD;
Plasmalyte® ... ... ml&#xD;
Glucose Serum 5% ....... ml&#xD;
Glucose serum 10% ........ ml&#xD;
Glucosaline serum ........ ml&#xD;
colloids:&#xD;
Hydroxyethyl starch 130 / 0.4 ... ... ml&#xD;
Hydroxyethyl alimdon 130 / 0.42 ... .... ml&#xD;
Gelatins ... ....... ml&#xD;
Albumin 5% .......... ml&#xD;
Albumin 20% .......... ml.&#xD;
Analyze the total amount of crystalloids and liquid colloids administered in 24 hours in milliliters.&#xD;
Analyze the form of administration:&#xD;
Standard&#xD;
Standard with dosimeters&#xD;
on pump</description>
    <arm_group_label>Adult patients undergoing surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study population The fluid therapy administered by the anesthesiologists (Operating Room,&#xD;
        PACU and resuscitation and critical units) will be recorded for all patients who are&#xD;
        operated during the 24 hours of the study and who meet the inclusion criteria. The 24 hours&#xD;
        of registration will be defined as the interval of 08:00 a.m. of the chosen day until 08:00&#xD;
        a.m. of the next day.&#xD;
&#xD;
        Participation in this study only involves conducting an interview and collecting data from&#xD;
        your clinical record referring to the 24 hours after your intervention, without making any&#xD;
        additional intervention.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years of age surgically treated during the 24 hours of the two-day&#xD;
             study of both scheduled and emergency surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Interventions performed outside the surgical area: complementary examination cabinets.&#xD;
&#xD;
          -  Interventions that do not require the presence of an anesthesiologist.&#xD;
&#xD;
          -  Ophthalmologic surgery&#xD;
&#xD;
          -  Surgery performed with local anesthesia.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitario Bellvitge</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Maria J Colomina, MD, PhD</last_name>
      <phone>0034 629993697</phone>
      <email>mjcolomina@bellvithehospital.cat</email>
    </contact>
    <investigator>
      <last_name>Maria J Colomina, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricia Guilabert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Javier Ripollés, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose L Jover, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Misericordia Basora, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Concepción Cassinello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Ferrandis, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan V LLau, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Basora M, Colomina MJ, Moral V, Asuero de Lis MS, Boix E, Jover JL, Llau JV, Rodrigo MP, Ripollés J, Calvo Vecino JM. Clinical practice guide for the choice of perioperative volume-restoring fluid in adult patients undergoing non-cardiac surgery. Rev Esp Anestesiol Reanim. 2016 Jan;63(1):29-47. doi: 10.1016/j.redar.2015.06.013. Epub 2015 Sep 3. English, Spanish.</citation>
    <PMID>26343809</PMID>
  </reference>
  <reference>
    <citation>Colomina MJ, Basora M, Moral V, Llau JV. Crystalloids and hydroxyethyl starches in noncardiac surgical patients. Eur J Anaesthesiol. 2017 Jan;34(1):28-29.</citation>
    <PMID>27136489</PMID>
  </reference>
  <reference>
    <citation>Calvo-Vecino JM, Ripollés-Melchor J, Mythen MG, Casans-Francés R, Balik A, Artacho JP, Martínez-Hurtado E, Serrano Romero A, Fernández Pérez C, Asuero de Lis S; FEDORA Trial Investigators Group. Effect of goal-directed haemodynamic therapy on postoperative complications in low-moderate risk surgical patients: a multicentre randomised controlled trial (FEDORA trial). Br J Anaesth. 2018 Apr;120(4):734-744. doi: 10.1016/j.bja.2017.12.018. Epub 2018 Feb 3.</citation>
    <PMID>29576114</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Aldecoa C. Goal-directed Hemodynamic Therapy: Neither for Anyone, Neither the Same for Everyone. Anesthesiology. 2018 Mar;128(3):682-683. doi: 10.1097/ALN.0000000000002050.</citation>
    <PMID>29438252</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Chappell D, Aya HD, Espinosa Á, Mythen MG, Abad-Gurumeta A, Bergese SD, Casans-Francés R, Calvo-Vecino JM. Erratum to: &quot;Fluid therapy recommendations for major abdominal surgery. Via RICA recommendations revisited. Part III: Goal directed hemodynamic therapy. Rationale for maintaining vascular tone and contractility&quot; [Rev Esp Anestesiol Reanim. 2017;64(6):348-359]. Rev Esp Anestesiol Reanim. 2017 Aug - Sep;64(7):425. doi: 10.1016/j.redar.2017.06.004. English, Spanish.</citation>
    <PMID>28709478</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Chappell D, Aya HD, Espinosa Á, Mythen MG, Abad-Gurumeta A, Bergese SD, Casans-Francés R, Calvo-Vecino JM. Erratum to: &quot;Fluid therapy recommendations for major abdominal surgery. Via RICA recommendations revisited. Part II: Goal directed hemodynamic therapy. Rationale for optimising intravascular volume&quot; [Rev Esp Anestesiol Reanim. 2017;64(6):339-347]. Rev Esp Anestesiol Reanim. 2017 Aug - Sep;64(7):424. doi: 10.1016/j.redar.2017.06.003. English, Spanish.</citation>
    <PMID>28709477</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Chappell D, Espinosa Á, Mythen MG, Abad-Gurumeta A, Bergese SD, Casans-Francés R, Calvo-Vecino JM. Erratum to: &quot;Perioperative fluid therapy recommendations for major abdominal surgery. Via RICA recommendations revisited. Part I: Physiological background&quot; [Rev Esp Anestesiol Reanim. 2017;64(6):328-338]. Rev Esp Anestesiol Reanim. 2017 Aug - Sep;64(7):423. doi: 10.1016/j.redar.2017.06.002. English, Spanish.</citation>
    <PMID>28709476</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Chappell D, Espinosa Á, Mhyten MG, Abad-Gurumeta A, Bergese SD, Casans-Francés R, Calvo-Vecino JM. Perioperative fluid therapy recommendations for major abdominal surgery. Via RICA recommendations revisited. Part I: Physiological background. Rev Esp Anestesiol Reanim. 2017 Jun - Jul;64(6):328-338. doi: 10.1016/j.redar.2017.02.008. Epub 2017 Mar 30. English, Spanish. Erratum in: Rev Esp Anestesiol Reanim. 2017 Aug - Sep;64(7):423.</citation>
    <PMID>28364973</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Chappell D, Aya HD, Espinosa Á, Mhyten MG, Abad-Gurumeta A, Bergese SD, Casans-Francés R, Calvo-Vecino JM. Fluid therapy recommendations for major abdominal surgery. Via RICA recommendations revisited. Part II: Goal directed hemodynamic therapy. Rationale for optimising intravascular volume. Rev Esp Anestesiol Reanim. 2017 Jun - Jul;64(6):339-347. doi: 10.1016/j.redar.2017.02.009. Epub 2017 Mar 24. English, Spanish. Erratum in: Rev Esp Anestesiol Reanim. 2017 Aug - Sep;64(7):424.</citation>
    <PMID>28343684</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Chappell D, Aya HD, Espinosa Á, Mhyten MG, Abad-Gurumeta A, Bergese SD, Casans-Francés R, Calvo-Vecino JM. Fluid therapy recommendations for major abdominal surgery. Via RICA recommendations revisited. Part III: Goal directed hemodynamic therapy. Rationale for maintaining vascular tone and contractility. Rev Esp Anestesiol Reanim. 2017 Jun - Jul;64(6):348-359. doi: 10.1016/j.redar.2017.03.002. Epub 2017 Mar 24. English, Spanish. Erratum in: Rev Esp Anestesiol Reanim. 2017 Aug - Sep;64(7):425.</citation>
    <PMID>28343682</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Álvarez-Baena L, Espinosa Á, Calvo-Vecino JM. Preoperative fluid loading in major abdominal surgery. Eur J Anaesthesiol. 2017 Jan;34(1):43-44.</citation>
    <PMID>27898485</PMID>
  </reference>
  <reference>
    <citation>Ripollés Melchor J, Fries D, Chappell D. Colloidophobia. Minerva Anestesiol. 2016 Oct;82(10):1039-1042. Epub 2016 Jun 28.</citation>
    <PMID>27352071</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Casans-Francés R, Espinosa A, Abad-Gurumeta A, Feldheiser A, López-Timoneda F, Calvo-Vecino JM; EAR Group, Evidence Anesthesia Review Group. Goal directed hemodynamic therapy based in esophageal Doppler flow parameters: A systematic review, meta-analysis and trial sequential analysis. Rev Esp Anestesiol Reanim. 2016 Aug-Sep;63(7):384-405. doi: 10.1016/j.redar.2015.07.009. Epub 2016 Feb 10. Review. English, Spanish.</citation>
    <PMID>26873025</PMID>
  </reference>
  <reference>
    <citation>Ripollés-Melchor J, Espinosa Á, Martínez-Hurtado E, Abad-Gurumeta A, Casans-Francés R, Fernández-Pérez C, López-Timoneda F, Calvo-Vecino JM. Perioperative goal-directed hemodynamic therapy in noncardiac surgery: a systematic review and meta-analysis. J Clin Anesth. 2016 Feb;28:105-15. doi: 10.1016/j.jclinane.2015.08.004. Epub 2015 Oct 2. Review.</citation>
    <PMID>26440438</PMID>
  </reference>
  <reference>
    <citation>Cecconi M, Hofer C, Teboul JL, Pettila V, Wilkman E, Molnar Z, Della Rocca G, Aldecoa C, Artigas A, Jog S, Sander M, Spies C, Lefrant JY, De Backer D; FENICE Investigators; ESICM Trial Group. Fluid challenges in intensive care: the FENICE study: A global inception cohort study. Intensive Care Med. 2015 Sep;41(9):1529-37. doi: 10.1007/s00134-015-3850-x. Epub 2015 Jul 11. Erratum in: Intensive Care Med. 2015 Sep;41(9):1737-8. multiple investigator names added.</citation>
    <PMID>26162676</PMID>
  </reference>
  <reference>
    <citation>Ripollés Melchor J, Espinosa Á, Martínez Hurtado E, Casans Francés R, Navarro Pérez R, Abad Gurumeta A, Calvo Vecino JM. Colloids versus crystalloids in the prevention of hypotension induced by spinal anesthesia in elective cesarean section. A systematic review and meta-analysis. Minerva Anestesiol. 2015 Sep;81(9):1019-30. Epub 2014 Dec 11. Review.</citation>
    <PMID>25501602</PMID>
  </reference>
  <reference>
    <citation>Ripollés Melchor J, Espinosa A. [Goal directed fluid therapy controversies in non-cardiac surgery]. Rev Esp Anestesiol Reanim. 2014 Nov;61(9):477-80. doi: 10.1016/j.redar.2014.09.001. Epub 2014 Oct 3. Spanish.</citation>
    <PMID>25284819</PMID>
  </reference>
  <reference>
    <citation>Meier J, Filipescu D, Kozek-Langenecker S, Llau Pitarch J, Mallett S, Martus P, Matot I; ETPOS collaborators. Intraoperative transfusion practices in Europe. Br J Anaesth. 2016 Feb;116(2):255-61. doi: 10.1093/bja/aev456.</citation>
    <PMID>26787795</PMID>
  </reference>
  <reference>
    <citation>Caballo C, Escolar G, Diaz-Ricart M, Lopez-Vílchez I, Lozano M, Cid J, Pino M, Beltrán J, Basora M, Pereira A, Galan AM. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates. Blood Transfus. 2013 Jul;11(3):391-9. doi: 10.2450/2012.0034-12. Epub 2012 Sep 19.</citation>
    <PMID>23058866</PMID>
  </reference>
  <reference>
    <citation>Basora M, Moral V, Llau JV, Silva S. [Perioperative colloid administration: a survey of Spanish anesthesiologists' attitudes]. Rev Esp Anestesiol Reanim. 2007 Mar;54(3):162-8. Spanish.</citation>
    <PMID>17436654</PMID>
  </reference>
  <reference>
    <citation>Basora M, Llau JV. [Survey on the perioperative use of colloids]. Rev Esp Anestesiol Reanim. 2004 Oct;51(8):479. Spanish.</citation>
    <PMID>15586550</PMID>
  </reference>
  <reference>
    <citation>Llau JV, Acosta FJ, Escolar G, Fernández-Mondéjar E, Guasch E, Marco P, Paniagua P, Páramo JA, Quintana M, Torrabadella P. Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document). Med Intensiva. 2015 Nov;39(8):483-504. doi: 10.1016/j.medin.2015.05.002. Epub 2015 Jul 29. English, Spanish.</citation>
    <PMID>26233588</PMID>
  </reference>
  <reference>
    <citation>Guilabert P, Usúa G, Martín N, Abarca L, Barret JP, Colomina MJ. Fluid resuscitation management in patients with burns: update. Br J Anaesth. 2016 Sep;117(3):284-96. doi: 10.1093/bja/aew266. Review.</citation>
    <PMID>27543523</PMID>
  </reference>
  <reference>
    <citation>Guilabert P, Abarca L, Martin N, Usua G, Barret JP, Colomina MJ. What about HES in burn patients?: Evaluation of the actual evidence. Burns. 2018 May;44(3):489-493. doi: 10.1016/j.burns.2017.09.023. Epub 2017 Oct 10.</citation>
    <PMID>29029856</PMID>
  </reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>June 30, 2018</study_first_submitted>
  <study_first_submitted_qc>August 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>August 9, 2018</last_update_submitted>
  <last_update_submitted_qc>August 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitari de Bellvitge</investigator_affiliation>
    <investigator_full_name>Maria José Clara Colomina Soler</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>fluid theraphy</keyword>
  <keyword>surgical procedures</keyword>
  <keyword>adult patients</keyword>
  <keyword>glycocalyx</keyword>
  <keyword>practice guideline</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Approval of the study by the AEMPS and the CEIC of the Bellvitge University Hospital February - March 2018.&#xD;
Throughout this period of time, the promotion and inclusion of the different participating centers will be carried out. In addition to simultaneously performing the online database by the Statistics Department of the IDIBELL Foundation - Barcelona.&#xD;
Obtaining the approvals of the CEICS and relevant entities.&#xD;
It is expected that the days to make the cut can be done in February 2019.&#xD;
Subsequently, the statistical analysis will be carried out and the results will be presented at the Meeting of the Haemostasis, Transfusion Medicine and Fluid Therapy Section of the SEDAR in 2019 and the results will be sent to the journal that is deemed appropriate for publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>At the end of 2019</ipd_time_frame>
    <ipd_url>http://fluidday.com</ipd_url>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_type>web page</doc_type>
      <doc_url>http://fluidday.com</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

